Dr. Kambridge Pirc Hribar, MD

Dr. Hribar practices at San Francisco Surgery Center in San Francisco, California.

Dr. Hribar's NPI, 1619100195, was assigned on August 31, 2009. Dr. Hribar graduated from Keck School of Medicine of USC in 2005. Dr. Hribar holds California license A97429.

Dr. Hribar's primary practice is San Francisco Surgery Center, at 450 Sutter Street, Suite 500, San Francisco, CA 94108. The practice phone is (415) 393-9600.

Dr. Hribar's primary practice is San Francisco Surgery Center in San Francisco, California. Dr. Hribar is also affiliated with California Pacific Medical Center Van Ness Campus. The medical group on file is Palo Alto Foundation Medical Group. Dmand AI also links Dr. Hribar to 4 more hospitals, 2 group practices and clinics, 2 medical groups and 1 physician office, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Hribar practices, 9 sites in all. Vendor and product names are available with a free account.

Otolaryngology is Dr. Hribar's primary specialty in the NPI Registry, under taxonomy code 207Y00000X. Dr. Hribar is board certified in otolaryngology by the American Board of Otolaryngology - Head and Neck Surgery. Dr. Hribar is licensed in California.

Dmand AI lists acute sinusitis, chronic ear infection, chronic nasal allergies, chronic sinusitis, ear eustachian tube disorders, ear infection, endoscopic sinus surgery and hearing loss and impairment among the conditions Dr. Hribar treats.

CMS data shows 2,486 Medicare services from Dr. Hribar across 10 procedure codes in 2024, for 1,033 Medicare patients. Medicare paid $232,037 for them. Every service was in an office.

CMS counts 1,033 Medicare patients who saw Dr. Hribar in 2024. The largest group is 75 to 84, with 472 patients. 75% of them have high cholesterol, and 57% have high blood pressure. 3% are also on Medicaid. Their average risk score is 0.96, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Hribar's median patient age at 64, with 57% women.

In 2024, Dr. Hribar wrote 853 Medicare Part D claims for 375 patients. 94% of them were for generic drugs. CMS names the drug for 754 of them, across 16 drugs with 11 or more claims each, at $155,852 in total drug cost. In 2023, CMS named 661 claims across 15 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 84 out of 100 for Dr. Hribar for performance year 2024, reported as part of a group. Dr. Hribar accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Hribar as offering telehealth.

Skin biopsy: 1 to 10 procedures (CMS shows small counts as a range)

Dmand AI links 1 paper to Dr. Hribar. Dr. Hribar's most frequent co-author is Joseph Charles Poen, MD.

CMS Open Payments shows 17 general payments to Dr. Hribar from 8 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 100% of the total. Sanofi and Genzyme US Companies paid the most, $108.

Dmand AI lists 1 award for Dr. Hribar, most recently CMS Stage 1 EHR in 2013.

Dr. Hribar graduated from Keck School of Medicine of USC in 2005.

Dr. Hribar is in network with 8 carriers, including Aetna, Blue Cross Blue Shield of Michigan and Elevance. Medicare plans come from the most carriers, 7. Check the plan with the practice before a visit.